View all cases
UPC CFI 2033/2025
Jul 4, 2025·EP4066856 · PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
- Case details
- StatusCase ClosedActionCounterclaim for revocationCategoryCounterclaim for revocation
- Parties
- Claimants
- Moderna Netherlands B.V.Operating co.
- Moderna Biotech Spain SLOperating co.
- Moderna Biotech UK LimitedOperating co.
- Moderna Biotech Distributor UK LtdOperating co.
- Moderna Switzerland GmbHOperating co.
- Moderna Poland Sp. z o.o.Operating co.
- Moderna, Inc.Operating co.
- ModernaTX, Inc.Operating co.
- Moderna Belgium S.R.L.Operating co.
- Moderna France SASUOperating co.
- Moderna Germany GmbHOperating co.
- Moderna Italy S.R.L.Operating co.
- Moderna Portugal Unipessoal LDAOperating co.
- Moderna Sweden ABOperating co.
- Moderna Norway ASOperating co.
Representatives- Gertjan Kuipers-Hogan Lovells International LLP
- Thomas Wolter-Mewburn Ellis LLP
- Division
- The Hague LD
- Technology
- ChemistryPharmaceuticals
- Language
- English
- First decided
- Feb 25, 2026
- EPO Opposition
- Thomann, WilliamAdmissible2023-09-06
- SANOFIAdmissible2023-09-06
- Weickmann & Weickmann PartmbBAdmissible2023-09-07
- JG Oppositions LimitedAdmissible2023-09-07
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| The Hague LD | Locked | Locked |
| Judge Edger Brinkman | Locked | Locked |
| Judge Margot Kokke | Locked | Locked |
| Judge Stefan Schilling | Locked | Locked |
| Judge Martin Schmidt | Locked | Locked |
At the UPC: Moderna Group (20 cases)·GlaxoSmithKline Biologicals SA (20 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 2 other proceedings
3 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: The Hague LD·2025
Decisions
- 2026-02-25Infringement ActionPublic
Summary: The Hague Local Division addressed GSK's R.263 application to amend its claim and Moderna's R.9 application to dismiss late-filed submissions in a parallel mRNA vaccine infringement action.
Show the legal issues (2)
- Amendment of claim Rule 263 RoP
- Late-filed submissions Rule 9 RoP
Documents
Show all 199 documents| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-08-10 | Not public |
| Order | 2026-08-10 | Not public |
| Order | 2026-08-10 | Not public |
| Receipt | 2026-07-25 | Not public |
| Cover sheet | 2026-07-25 | Not public |
| Application document Claimant | 2026-07-25 | Not public |
| Interim procedure opened | 2026-07-24 | Not public |
| Written procedure closed | 2026-07-24 | Not public |
| Receipt | 2026-05-20 | Not public |
| Cover sheet | 2026-05-20 | Not public |